REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,979,193 | +146.7% | 39,027 | +119.9% | 0.00% | 0.0% |
| Q1 2023 | $1,613,284 | +1608.9% | 17,744 | +614.0% | 0.00% | – |
| Q4 2022 | $94,405 | -96.4% | 2,485 | -97.6% | 0.00% | -100.0% |
| Q3 2022 | $2,607,000 | +3242.3% | 103,758 | +3956.2% | 0.00% | – |
| Q2 2022 | $78,000 | +32.2% | 2,558 | +42.2% | 0.00% | – |
| Q1 2022 | $59,000 | -36.6% | 1,799 | -49.4% | 0.00% | – |
| Q4 2021 | $93,000 | -89.1% | 3,558 | -58.0% | 0.00% | – |
| Q3 2021 | $852,000 | -18.4% | 8,472 | +14.8% | 0.00% | – |
| Q2 2021 | $1,044,000 | +61.1% | 7,379 | +13.5% | 0.00% | – |
| Q1 2021 | $648,000 | -66.9% | 6,504 | -58.9% | 0.00% | -100.0% |
| Q4 2020 | $1,957,000 | -48.9% | 15,837 | -59.7% | 0.00% | 0.0% |
| Q3 2020 | $3,833,000 | +118.9% | 39,343 | +250.6% | 0.00% | 0.0% |
| Q2 2020 | $1,751,000 | +284.0% | 11,221 | +255.0% | 0.00% | – |
| Q1 2020 | $456,000 | -85.6% | 3,161 | -79.7% | 0.00% | -100.0% |
| Q4 2019 | $3,176,000 | +563.0% | 15,536 | +160.9% | 0.00% | – |
| Q3 2019 | $479,000 | -24.7% | 5,955 | -11.6% | 0.00% | – |
| Q2 2019 | $636,000 | -73.6% | 6,738 | -76.1% | 0.00% | -100.0% |
| Q1 2019 | $2,412,000 | +56.4% | 28,221 | +2.7% | 0.00% | 0.0% |
| Q4 2018 | $1,542,000 | -28.9% | 27,483 | +3.6% | 0.00% | 0.0% |
| Q3 2018 | $2,169,000 | +76.9% | 26,524 | -24.3% | 0.00% | 0.0% |
| Q2 2018 | $1,226,000 | +199.8% | 35,045 | +75.8% | 0.00% | – |
| Q1 2018 | $409,000 | +313.1% | 19,933 | +473.6% | 0.00% | – |
| Q4 2017 | $99,000 | +35.6% | 3,475 | +46.9% | 0.00% | – |
| Q3 2017 | $73,000 | -30.5% | 2,365 | -29.0% | 0.00% | – |
| Q2 2017 | $105,000 | +288.9% | 3,332 | +172.4% | 0.00% | – |
| Q1 2017 | $27,000 | -50.0% | 1,223 | -50.8% | 0.00% | – |
| Q4 2016 | $54,000 | +35.0% | 2,488 | +24.4% | 0.00% | – |
| Q2 2016 | $40,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |